Latest Articles

New 2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin Combination Is Recommended

ADA/EASD recommend considering combination injectables therapy of basal insulin/GLP-1 RA (Such as Soliqua^®) as valuable treatment option to provide adequate efficacy for achieving and maintaining glycemic goals.

Diabetes management during Ramadan

Management of athletes and active people with diabetes - The American Medical Society for Sports Medicine (AMSSM) scientific statement

Post-exercise hypoglycemia in relation to medication regimen among adults with type 2 diabetes

Asthma Control Tests (ACT) overview

Saudi initiatives on Bronchiolitis Recommendations

The first choice of RSV prevention is Nirsevimab; alternatively, palivizumab is to be considered in case of unavailability of Nirsevimab.

FeNO Is a Clinically Useful Biomarker of Type 2 Inflammation in Pediatric Patients With Asthma

Implementing Beyfortus successfully

Prevalence of Asthma